Chapter 15 and Chapter 16 Biol exam 222 – Flashcards
Unlock all answers in this set
Unlock answersquestion
1. How do cells become transformed into a clonal population of cancer cells?
answer
a. Cancer cells divide rapidly and continuously, resulting in tumors that crowd out normal cells i. Somatic cells, never gonna be sperms or eggs (fyi) b. Mutations in certain genes of it
question
2. How do defects in cell cycle control lead to cancer?
answer
a. Mutations in the cell check points. b. Various checkpoints serve as monitors as the status of DNA repair, replication, and spindle apparatus formation, etc
question
How do mutations in tumor suppressor genes and proto-oncogenes contribute to cancer?
answer
a. Tumor Suppressor Genes - b. Mutations in these genes lose the ability to inhibit proliferation. i. Proteins involved in inhibiting progression of the cell cycle (e.g. RB). ii. Proteins involved in the repair of DNA damage (e.g. p53). iii. Proteins that promote apoptosis (e.g. p53). c. Proto-oncogenes i. Dominant oncogenes -- Mutant proto-oncogenes that promote proliferation without the signal
question
Tumor Suppressor Genes -
answer
...
question
Mutations in these genes lose the ability to inhibit proliferation.
answer
i. Proteins involved in inhibiting progression of the cell cycle (e.g. RB). ii. Proteins involved in the repair of DNA damage (e.g. p53). iii. Proteins that promote apoptosis (e.g. p53).
question
Proto-oncogenes
answer
i. Dominant oncogenes -- Mutant proto-oncogenes that promote proliferation without the signal
question
Understand the G1
answer
S cell cycle control checkpoint. a. G1—S Checkpoint i. Deals with CDK, if the RB and the E3F are phosphorylated, it'll make the RB no longer bound to E2F. E2F will become a transcription factor required for DNA replication.
question
Xerogerma Pigmentsum
answer
i. Mutation in a general exicision repair gene; prone to UV-induced mutations
question
Chronic Myeloid Leukemia (CMS)
answer
i. Bone marrow cell cancer, between chromosome 22 and 9 1. Result in Philadelphia chromosome
question
Burkitt Lymphoma
answer
i. B lymphocyte cancer 1. Myc transcribed at all times (transcription
question
Helicobacterpylori (bacteria
answer
i. Ulcers and stomach cancer
question
Human Papilloma Virus (HPV)
answer
i. Causes cervical cancer
question
Hepatitis B and C viruses
answer
...
question
Understand what the Hardy-Weinberg equilibrium is and the forces that disturb this equilibrium.
answer
b. Assumes that the population is: i. large (i.e. no genetic drift) ii. randomly mating iii. no new mutation iv. no migration v. no natural selection
question
Genetic Drift
answer
a. Sampling error, founder effect, genetic bottleneck
question
Mutation
answer
a. Germinal Mutation i. Raw source of evolution
question
Migration
answer
a. Movement of alleles into and out of a population
question
Mating
answer
a. Inbreeding and positive assortative mating lead to decreased heterozygosity. b. Outbreeding and negative assortative mating lead to increased heterozygosity.
question
Inbreeding and positive assortative mating lead
answer
decreased heterozygosity
question
Outbreeding and negative assortative mating lead to
answer
increased heterozygosity
question
How are new genes acquired?
answer
1. Mating and/or migration
question
Learn about hominid evolution
answer
...
question
Understand the evolutionary relationships of the concestors that I discussed during the evolutionary pilgrimage lecture.
answer
...
question
Ch15 Q 2. * What is the difference between a map-based approach to sequencing a whole genome and a whole-genome shotgun approach?
answer
Answer: The map-based approach first assembles large clones into contigs on the basis of genetic and physical maps and then selects clones for sequencing. The whole-genome shotgun approach breaks the genome into short sequences—typically, from 600 to 700 bp—and then, with the use of powerful computers, assembles them into contigs on the basis of sequence overlap.
question
Ch15 Q3. What is a single-nucleotide polymorphism (SNP)? How are SNPs used in genomic studies?
answer
...
question
Ch15 Q 7. What is a microarray? How can it be used to obtain information about gene function?
answer
...
question
Ch 16 Q1. In some cancer cells, a specific gene has become duplicated many times. Is this gene likely to be an oncogene or a tumor-suppressor gene? Explain your reasoning.
answer
The gene is likely to be an oncogene. Oncogenes stimulate cell proliferation and act in a dominant manner. Therefore, extra copies of an oncogene will result in cell proliferation and cancer. Tumor-suppressor genes, on the other hand, suppress cell proliferation and act in a recessive manner; a single copy of a tumor-suppressor gene is sufficient to prevent cell proliferation. Therefore, extra copies of the tumor-suppressor gene will not lead to cancer.
question
Ch16 Q 1 * What types of evidence indicate that cancer arises from genetic changes?
answer
Many types of cancer are associated with exposure to radiation and other environmental mutagens. Some types of cancer tend to run in families, and a few cancers are linked to chromosomal abnormalities. Finally, the discovery of oncogenes and specific mutations that cause proto-oncogenes to become oncogenes or that inactivate tumor-suppressor genes proved that cancer has a genetic basis.
question
Ch16 Q 5. * What is the difference between an oncogene and a tumor-suppressor gene? Give some examples of the functions of proto-oncogenes and tumor suppressers in normal cells.
answer
Oncogenes stimulate cell division, whereas tumor-suppressor genes put the brakes on cell growth. Proto-oncogenes are normal cellular genes that function in cell growth and in the regulation of the cell cycle. Some examples are erbA, erbB, myc, src, and ras. Tumor-suppressor genes inhibit cell-cycle progression; examples are RB and p53, which encode transcription factors.
question
Ch16 Q 6. * How do cyclins and CDKs differ? How do they interact in controlling the cell cycle?
answer
The CDKs, or cyclin-dependent kinases, have enzymatic activity and phosphorylate multiple substrate molecules when activated by binding to the appropriate cyclin. Cyclins are regulators of CDKs and have no enzymatic activity of their own. Each cyclin molecule binds to a single CDK molecule. Whereas CDK levels remain relatively stable, cyclin levels oscillate in the course of the cell cycle.
question
Ch 16 Q9. * What role do telomeres and telomerase play in cancer progression?
answer
DNA polymerases are unable to replicate the ends of linear DNA molecules. Therefore, the ends of eukaryotic chromosomes shorten with every round of DNA replication, unless telomerase uses its RNA component to add back telomeric DNA sequences, which it does in reproductive cells. Normally, somatic cells do not express telomerase; their telomeres progressively shorten with each cell division until vital genes are lost and the cells undergo apoptosis. Transformed cells (cancerous cells) induce the expression of the telomerase gene, thus leading to cell proliferation.
question
ch 16 Q 10. * Explain how chromosome deletions, inversions, and translocations can cause cancer.
answer
Deletions can cause the loss of one or more tumor-suppressor genes. Inversions and translocations can inactivate tumor-suppressor genes if the chromosomal breakpoints are within tumor-suppressor genes. Alternatively, a translocation can place a proto-oncogene in a new location, where it is activated by different regulatory sequences, causing the overexpression or unregulated expression of the proto-oncogene. Finally, inversions and translocations can also bring parts of two different genes together, causing the synthesis of a novel protein that is oncogenic.
question
ch 16 Q13. * How do viruses contribute to cancer?
answer
Retroviruses have strong promoters. After its integration into a host genome, a retrovirus promoter can drive the overexpression of a cellular proto-oncogene. Alternatively, the integration of a retrovirus can inactivate a tumor-suppressor gene. A few retroviruses carry oncogenes that are altered versions of host proto-oncogenes. Other viruses, such as the human papilloma virus, produce proteins that affect the cell cycle.